|
PT2931898E
(pt)
|
2012-12-12 |
2016-06-16 |
Harvard College |
Manipulação e otimização de sistemas, métodos e composições para manipulação de sequências com domínios funcionais
|
|
WO2015089473A1
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Engineering of systems, methods and optimized guide compositions with new architectures for sequence manipulation
|
|
US10648020B2
(en)
|
2015-06-18 |
2020-05-12 |
The Broad Institute, Inc. |
CRISPR enzymes and systems
|
|
AU2016279062A1
(en)
|
2015-06-18 |
2019-03-28 |
Omar O. Abudayyeh |
Novel CRISPR enzymes and systems
|
|
US9790490B2
(en)
|
2015-06-18 |
2017-10-17 |
The Broad Institute Inc. |
CRISPR enzymes and systems
|
|
US11352647B2
(en)
|
2016-08-17 |
2022-06-07 |
The Broad Institute, Inc. |
Crispr enzymes and systems
|
|
CN117487776A
(zh)
*
|
2017-11-01 |
2024-02-02 |
加利福尼亚大学董事会 |
Casz组合物和使用方法
|
|
WO2019089808A1
(en)
*
|
2017-11-01 |
2019-05-09 |
The Regents Of The University Of California |
Class 2 crispr/cas compositions and methods of use
|
|
US11667917B2
(en)
|
2017-11-21 |
2023-06-06 |
Genkore Co. Ltd. |
Composition for genome editing using CRISPR/CPF1 system and use thereof
|
|
EP3875469A4
(en)
|
2018-10-29 |
2022-08-17 |
China Agricultural University |
NOVEL CRISPR/CAS12F ENZYME AND SYSTEM
|
|
US12258594B2
(en)
|
2018-12-05 |
2025-03-25 |
The Broad Institute, Inc. |
Cas proteins with reduced immunogenicity and methods of screening thereof
|
|
CN113166744B
(zh)
|
2018-12-14 |
2025-02-07 |
先锋国际良种公司 |
用于基因组编辑的新颖crispr-cas系统
|
|
EP4219700A1
(en)
*
|
2019-03-07 |
2023-08-02 |
The Regents of the University of California |
Crispr-cas effector polypeptides and methods of use thereof
|
|
WO2020223634A1
(en)
|
2019-05-01 |
2020-11-05 |
Mammoth Biosciences, Inc. |
Programmable nucleases and methods of use
|
|
EP3772329A1
(fr)
*
|
2019-08-08 |
2021-02-10 |
PKvitality |
Systeme de surveillance corporelle comprenant une microaiguille
|
|
IL292571A
(en)
*
|
2019-10-28 |
2022-06-01 |
Targetgene Biotechnologies Ltd |
Pam-reduced and pam-abolished cas derivatives compositions and uses thereof in genetic modulation
|
|
CN114846146B
(zh)
|
2019-10-29 |
2024-04-12 |
基恩科雷有限责任公司 |
用于增加CRISPR/Cas12f1系统的效率的工程化引导RNA及其用途
|
|
KR20230076820A
(ko)
|
2020-09-01 |
2023-05-31 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
진핵생물 유전체 공학을 위한 합성 미니어처 crispr-cas(casmini) 시스템
|
|
CN116568803A
(zh)
|
2020-10-08 |
2023-08-08 |
基恩科雷有限责任公司 |
用于增加CRISPR/Cas12f1系统的效率的包含富含U的尾部的经工程化的引导RNA及其用途
|
|
JP2023544817A
(ja)
|
2020-10-08 |
2023-10-25 |
ゲンコレ インコーポレイテッド |
CRISPR/Cas12f1システム効率化のためのエンジニアリングされたガイドRNAおよびその用途
|
|
WO2022075816A1
(ko)
|
2020-10-08 |
2022-04-14 |
주식회사 진코어 |
Crispr/cas12f1(cas14a1) 시스템 효율화를 위한 엔지니어링 된 가이드 rna 및 이의 용도
|
|
EP4267252A4
(en)
|
2020-12-23 |
2025-07-23 |
Mammoth Biosciences Inc |
COMPOSITIONS AND METHODS OF USING PROGRAMMABLE NUCLEASES TO INDUCE CELL DEATH
|
|
US20240060088A1
(en)
|
2021-01-05 |
2024-02-22 |
Horizon Discovery Limited |
Guide RNA Designs and Complexes for Type V Cas Systems
|
|
JP2024523394A
(ja)
|
2021-06-17 |
2024-06-28 |
エピクリスパー バイオテクノロジーズ, インコーポレイテッド |
異常な遺伝子発現を調節するためのシステムおよび方法
|
|
KR20230007218A
(ko)
*
|
2021-07-05 |
2023-01-12 |
주식회사 진코어 |
초소형 염기교정 시스템 및 이의 용도
|
|
JP2024526895A
(ja)
|
2021-07-20 |
2024-07-19 |
エピクリスパー バイオテクノロジーズ, インコーポレイテッド |
標的遺伝子を調節するための系および方法
|
|
AU2022318664A1
(en)
|
2021-07-30 |
2024-02-29 |
Tune Therapeutics, Inc. |
Compositions and methods for modulating expression of methyl-cpg binding protein 2 (mecp2)
|
|
JP2025507822A
(ja)
|
2022-03-01 |
2025-03-21 |
エピクリスパー バイオテクノロジーズ, インコーポレイテッド |
組換えヌクレアーゼならびにその組成物および使用方法
|
|
WO2023172995A1
(en)
|
2022-03-11 |
2023-09-14 |
Epicrispr Biotechnologies, Inc. |
Systems and methods for genetic modulation to treat ocular diseases
|
|
WO2023173120A1
(en)
|
2022-03-11 |
2023-09-14 |
Epicrispr Biotechnologies, Inc. |
Systems and methods for genetic modulation to treat ocular diseases
|
|
EP4490294A4
(en)
|
2022-03-11 |
2026-03-18 |
Epicrispr Biotechnologies Inc |
GENETIC MODULATION SYSTEMS AND METHODS FOR TREATING LIVER DISEASE
|
|
WO2023173110A1
(en)
|
2022-03-11 |
2023-09-14 |
Epicrispr Biotechnologies, Inc. |
Compositions, systems, and methods for treating familial hypercholesterolemia by targeting pcsk9
|
|
JP2025510781A
(ja)
|
2022-03-24 |
2025-04-15 |
エピクリスパー バイオテクノロジーズ, インコーポレイテッド |
組換え遺伝子エフェクターならびにその組成物および使用方法
|